Journal
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
Volume 105, Issue 2, Pages 150-153Publisher
WILEY
DOI: 10.1016/j.ijgo.2008.12.017
Keywords
Cervical cancer; Human papillomavirus genotyping; Polymerase chain reaction-reverse-line blotting assay
Categories
Funding
- GlaxoSmithKline Biologicals [108805]
Ask authors/readers for more resources
Objective: To determine the prevalence rates of the different HPV types in cervical cancer lesions in Chile to facilitate the development of prophylactic human papillomavirus (HPV) vaccines effective for that country. Method: Biopsy samples of 312 cervical cancer lesions were assessed for HPV type by reverse-line blotting assay. Results: HPV DNA was found in 94.2% of the lesions, 67.2% harboring 1 viral type and the remainder harboring more than 1 type. HPV-16 was the most frequent type in single infections (50.5%), followed by HPV-18 (7.8%), HPV-31 (2.4%), and HPV-45 (2.0%). HPV-16 was also present in 98.7% of dual and multiple infections, its most frequent association being with HPV-18. Conclusions: HPV types 16,18, 31, and 45, alone or combined with other types, were observed in the biopsy samples of up to 80.5% of cervical cancer lesions. (C) 2008 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available